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ABSTRACT Hepatitis C virus (HCV) nonstructural protein 5A (NS5A) is a phospho-
protein that plays key, yet poorly deﬁned, roles in both virus genome replication
and virion assembly/release. It has been proposed that differential phosphorylation
could act as a switch to regulate the various functions of NS5A; however, the mech-
anistic details of the role of this posttranslational modiﬁcation in the virus life cycle
remain obscure. We previously reported (D. Ross-Thriepland, J. Mankouri, and M.
Harris, J Virol 89:3123–3135, 2015, doi:10.1128/JVI.02995-14) a role for phosphoryla-
tion at serine 225 (S225) of NS5A in the regulation of JFH-1 (genotype 2a) genome
replication. A phosphoablatant (S225A) mutation resulted in a 10-fold reduction in
replication and a perinuclear restricted distribution of NS5A, whereas the corre-
sponding phosphomimetic mutation (S225D) had no phenotype. To determine the
molecular mechanisms underpinning this phenotype we conducted a label-free pro-
teomics approach to identify cellular NS5A interaction partners. This analysis re-
vealed that the S225A mutation disrupted the interactions of NS5A with a number
of cellular proteins, in particular the nucleosome assembly protein 1-like protein 1
(NAP1L1), bridging integrator 1 (Bin1, also known as amphiphysin II), and vesicle-
associated membrane protein-associated protein A (VAP-A). These interactions were
validated by immunoprecipitation/Western blotting, immunoﬂuorescence, and prox-
imity ligation assay. Importantly, small interfering RNA (siRNA)-mediated knockdown
of NAP1L1, Bin1 or VAP-A impaired viral genome replication and recapitulated the
perinuclear redistribution of NS5A seen in the S225A mutant. These results demon-
strate that S225 phosphorylation regulates the interactions of NS5A with a deﬁned
subset of cellular proteins. Furthermore, these interactions regulate both HCV ge-
nome replication and the subcellular localization of replication complexes.
IMPORTANCE Hepatitis C virus is an important human pathogen. The viral nonstruc-
tural 5A protein (NS5A) is the target for new antiviral drugs. NS5A has multiple func-
tions during the virus life cycle, but the biochemical details of these roles remain
obscure. NS5A is known to be phosphorylated by cellular protein kinases, and in this
study, we set out to determine whether this modiﬁcation is required for the binding
of NS5A to other cellular proteins. We identiﬁed 3 such proteins and show that they
interacted only with NS5A that was phosphorylated on a speciﬁc residue. Further-
more, these proteins were required for efﬁcient virus replication and the ability of
NS5A to spread throughout the cytoplasm of the cell. Our results help to deﬁne the
function of NS5A and may contribute to an understanding of the mode of action of
the highly potent antiviral drugs that are targeted to NS5A.
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Hepatitis C virus (HCV) infects approximately 130 to 170 million individuals world-wide and is a leading cause of liver disease (1). There is no vaccine available, and
current antiviral treatments are less effective against some viral strains (2). HCV belongs
to the Flaviviridae family (genus Hepacivirus) of enveloped viruses with a positive-sense
RNA genome (9.6 kb) coding for a single polyprotein that is processed co- and
posttranslationally by viral and host proteases, yielding four structural proteins (core,
E1, E2, and p7) and six nonstructural proteins (NS2, NS3, NS4A, NS4B, NS5A, and NS5B)
(3). NS3 to NS5B are necessary and sufﬁcient for viral genome replication (4) and thus
constitute the essential components of the genome replication complex. Further to its
requirement in genome replication, NS5A has been shown to play a critical role in virion
assembly, as discussed below.
Early in infection, HCV remodels endoplasmic reticulum (ER)-derived membranes to
form a “membranous web” (MW) comprised of single, double, and multimembrane
vesicles (SMVs, DMVs, and MMVs) that are enriched in viral (e.g., NS3, NS5A, and NS5B)
and host cell proteins (5, 6). The MW is proposed as the site of viral genome replication,
and in Huh7 cells, the MW is extensively distributed throughout the cytoplasm,
correlating with the observed subcellular distribution of NS5A as discrete punctae
throughout the cytoplasm. The cellular lipid kinase, phosphatidylinositol kinase type III
alpha isoform (PI4KIII), is activated by NS5A (7), and the subsequent increase in
abundance of phosphatidylinositol-4-phosphate (PI4P) is critical for establishment and
maintenance of the MW (8–10). NS5A is also thought to be involved in delivery of
nascent virus genomes from the MW to sites of assembly. While the latter are yet to be
unambiguously deﬁned, it is accepted that an association of both NS5A and the HCV
capsid (core) protein with lipid droplets (LDs; a host organelle responsible for storage
of neutral lipids) is required during this process. It has been hypothesized that NS5A
switches from a role in replication to an alternative function in assembly which might
involve transporting nascent genomes via LDs to assembly sites.
In this regard, NS5A is highly phosphorylated, and it is possible that this reversible
posttranslational modiﬁcation could mediate a switch in NS5A function, by altering
protein conformation and/or protein-protein interactions. NS5A comprises three do-
mains and is tethered to membranes by an N-terminal amphipathic helix (Fig. 1b).
Domain I is highly structured (11–13), while domains II and III are intrinsically disor-
dered, with elements of transient secondary structure (14). The domains are linked by
low-complexity sequences (LCS); LCSI is serine rich, and LCSII is proline rich. To address
the potential functional role of NS5A phosphorylation, we and others have used mass
spectrometry (MS) to identify phosphorylation sites (15–20). These studies have iden-
tiﬁed multiple phosphorylation sites, but in particular they show that LCSI is highly
phosphorylated. Subsequent mutagenesis of these phosphorylation sites revealed that
a subset of them is required for efﬁcient genome replication. In particular, a number of
groups have presented evidence that phosphorylation of serine 235 is critical, as
replacement of this residue with alanine (S235A) resulted in a 100-fold reduction in
genome replication (15–17, 21). It should be noted that other approaches, such as in
vitro phosphorylation assays, genetic approaches, and use of selective inhibitors, have
identiﬁed additional sites toward the C terminus of NS5A, such as T360 (22) and S457
(23).
In this study, we focused on another phosphorylated residue within LCSI: serine 225.
We demonstrated previously that phosphorylation of serine 225 was required for
efﬁcient genome replication and contributed to the subcellular localization of viral
proteins during infection (19, 24). Alanine substitution (S225A) resulted in a 10-fold
reduction in genome replication and was concomitant with a restricted distribution of
NS5A, and other factors known to participate in genome replication (NS3 and PI4P
lipids), to a perinuclear region (24). This restriction was dramatic compared to the
extensive distribution of these components throughout the cytoplasm in wild-type
(WT)-infected cells.
To understand the molecular mechanism underpinning the phenotype of the S225A
mutation, we hypothesized that it might be explained by a role of S225 phosphoryla-
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tion in regulating interactions between NS5A and cellular proteins. To address this, we
used afﬁnity puriﬁcation of One-Strep-tagged NS5A in conjunction with label-free
quantitative proteomics analysis to compare the interactome of wild-type and S225
mutants of NS5A. In this study, we focused on 3 cellular proteins—nucleosome
assembly protein 1-like protein 1 (NAP1L1), bridging integrator 1 (Bin1, also known as
amphiphysin II), and vesicle-associated membrane protein-associated protein A
FIG 1 Construction and validation of One-Strep-tagged (OST) NS5A neomycin reporter SGR JFH-1. (a) Schematic of SGR-Neo-
JFH-1-5A-OST. (b) NS5A structure showing amino acid residues for LCSI and location of the OST. The OST was introduced
between residues 418 and 419, a site previously shown to tolerate insertions (25). AH, amphipathic helix; neo, neomycin
phosphotransferase. (c) G418-resistant Huh7 cells stably harboring the SGRs were isolated by selective culture. Cells were lysed
and analyzed by Western blotting for NS5A or glyceraldehyde-3-phosphate dehydrogenase (GAPDH). (d) SGR-harboring Huh7
cells (left) or Huh7-Lunet T7 cells transfected with pTM-NS3-5B plasmids (right) were seeded onto coverslips, ﬁxed at 48 h
posttransfection (hpt), and permeabilized prior to staining with a sheep polyclonal anti-NS5A serum and Alexa Fluor 594
secondary antibody. Scale bars, 30 m and 20 m. (e) Huh7 cells stably harboring wild-type, S225D, or S225A SGRs were ﬁxed,
immunostained for NS5A (Alexa Fluor 647-labeled 9E10), and imaged by dSTORM. Images were reconstructed from 873185,
354952, and 641609 localizations for wild-type, S225D, and S225A SGRs, respectively. Histogram bins of 100 nm and 10 nm
(with image smoothing) were used for the left and right images, respectively. Scale bars, 5 m (left) and 500 nm (right). (f) Size
of NS5A protein clusters identiﬁed by DBSCAN analysis. The mean Euclidean distance between each localization to every other
localization in an identiﬁed cluster was measured. Data represent the means  SEM from three independent cells containing
2,062, 1,561, and 1,515 clusters from wild-type, S225D, and S225A SGRs, respectively. Signiﬁcant differences are indicated as
follows: **, P  0.005, and ****, P  0.0001.
Role of NS5A S225 Phosphorylation Journal of Virology
September 2017 Volume 91 Issue 17 e00805-17 jvi.asm.org 3
 o
n
 Septem
ber 4, 2017 by UNIVERSITY O
F LEEDS
http://jvi.asm.org/
D
ow
nloaded from
 
(VAP-A)—that exhibited a loss of interaction with S225A mutant NS5A compared to the
wild type and the S225D mutant. In contrast, the binding of VAP-B to NS5A was not
dependent on S225 phosphorylation and acted as a control. These interactions were
validated by immunoprecipitation, immunoﬂuorescence, and proximity ligation assay
(PLA). Furthermore, small interfering RNA (siRNA) ablation of endogenous NAP1L1,
Bin1, and VAP-A reduced both HCV RNA replication and NS5A expression signiﬁcantly;
however, consistent with lack of dependence on S225 phosphorylation, VAP-B ablation
had a modest effect. Importantly, ablation of NAP1L1, Bin1, and VAP-A recapitulated
the restricted distribution of the NS5A protein. We propose that S225 phosphorylation
is required for the interaction of NS5A with these cellular proteins and enables the
formation and distribution of replication complexes throughout the cytoplasm, thereby
enhancing the efﬁciency of genome replication.
RESULTS
Identiﬁcation of serine 225 phosphorylation-dependent NS5A-interacting pro-
teins. Previously, we reported that phosphorylation of serine 225 within LCSI of NS5A
played a role in the regulation of JFH-1 genome replication (24). Mutation of this
residue to alanine (S225A; phosphoablatant) resulted in a 10-fold reduction in genome
replication and altered subcellular distribution of NS5A, whereas the phosphomimetic
mutation (S225D) had no phenotype. To understand the mechanism behind this
phenotype, we sought to identify cellular proteins that interacted with NS5A in an S225
phosphorylation-dependent fashion. For this, we exploited the One-Strep tag (OST)
afﬁnity puriﬁcation strategy that we had previously used to identify sites of phosphor-
ylation within NS5A (19). The OST is a peptide that structurally resembles biotin and
binds to recombinant streptavidin (Strep-Tactin). S225A and S225D mutations were
cloned into pSGR-Neo-JFH-1-5A-OST, which contained the OST cloned into a well-
tolerated insertion site near the C terminus of NS5A domain III (25) (Fig. 1a and b). These
subgenomic replicons (SGRs) were used to establish stable Huh7 cell lines expressing
either the wild-type or the two mutant SGRs. The phenotype of these mutants was
conﬁrmed by Western blotting and ﬂuorescence microscopy (Fig. 1c and d). As ex-
pected (24), the S225A mutation resulted in a reduction in hyperphosphorylation (Fig.
1c) and in a distribution of the protein that was restricted to the perinuclear region (Fig.
1d). We had previously demonstrated that this phenotype was not a consequence of
the reduced level of RNA replication exhibited by the S225A mutant (24). We further
conﬁrmed this by expressing either wild-type or S225A mutant NS5A in the context of
the NS3-NS5B polyprotein from a T7 RNA polymerase-driven construct (pTM, a kind gift
from Volker Lohmann). Following transfection of these plasmids into Huh7-Lunet T7
cells (stably expressing T7 RNA polymerase, also a kind gift from Volker Lohmann), the
restricted distribution of NS5A S225A was recapitulated (Fig. 1d), conﬁrming that the
phenotype was not dependent on genome replication or the level of NS5A expression.
We also applied a superresolution approach (Fig. 1e and f), and this revealed an
additional S225A phenotype: discrete clusters of NS5A localizations were equivalent to
the diffraction limited puncta observed by wide-ﬁeld microscopy. Clusters were ob-
served distributed throughout the cytoplasm apart from the S225A mutant, which was
more condensed and perinuclear. Consistent with our previous ﬁndings (24), larger
NS5A clusters were observed for the S225A mutant than for the wild type and the
S225D mutant. Taken together, these data demonstrate that S225 phosphorylation
regulated not only the distribution of the replication complexes but also their archi-
tecture. These observations gave further impetus for the need to understand the
molecular mechanism behind this phenotype.
To identify cellular candidates that are potentially involved in the S225A phenotype,
we next performed afﬁnity puriﬁcation from cytoplasmic lysates of Strep-tagged wild-
type, S225A, and S225D NS5A and analyzed the bound fractions by mass spectrometry.
A large number of known NS5A binding proteins were identiﬁed by this procedure.
Wild-type NS5A and S225D mutant NS5A showed no difference in their binding to
associated proteins (see Data Set S1 in the supplemental material). As we were
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interested in the role of S225 phosphorylation, we mined the data set for those cellular
proteins that bound well to wild-type or S225D NS5A but exhibited a reduced level of
interaction with S225A mutant NS5A (Fig. 2). We focused on three of these differentially
enriched proteins. Bin1 (also known as amphiphysin II) is a BAR domain-containing
protein involved in generating membrane curvature and was previously characterized
as an NS5A interactor (26–28). VAP-A (also known as hVAP-33) is a vesicle-associated
protein previously shown to participate in the formation of HCV genome replication
complexes and to bind to NS5A (29–32). As well as these previously characterized NS5A
partners, we also focused on the nucleosome assembly protein 1-like proteins 1 and 4
(NAP1L1 and NAP1L4). NAP1L1 has been shown to interact with HCV core and NS5A
(33, 34) as well as Kaposi’s sarcoma herpesvirus (KSHV) LANA (35) and HIV-1 Tat (36).
Although its roles in the nucleus associated with chromatin structure and gene
expression are well deﬁned, NAP1L1 is predominantly located in the cytoplasm, where
its function(s) remains to be elucidated. We chose these proteins for further analysis
FIG 2 Proteomic analysis of NS5A-interacting proteins. OST-tagged wild-type (wt), S225A, and S225D
NS5A proteins were afﬁnity puriﬁed from Huh7 cells stably harboring SGRs, and associated proteins were
identiﬁed by LC-MS/MS. Four independent afﬁnity puriﬁcations were performed for each bait. (a) Volcano
plot displaying the average degree of enrichment by wt NS5A over S225A NS5A (ratio of label-free
quantiﬁcation [LFQ] protein intensities) and the P value (Welch’s t test) for each protein. Signiﬁcantly
enriched cellular proteins are highlighted in red. (b) Heat map showing nonimputed log2 transformed
LFQ intensities for each individual replicate in rainbow colors (see color scale). Only the bait protein and
selected cellular interaction partners are depicted in the plot. Gray color represents missing values (not
determined [ND]).
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because they exhibited the greatest difference between wild-type and S225A NS5A
(Fig. 2b) and thus represented the best candidates to explain the mechanism under-
pinning the S225A phenotype. As a control, we also examined VAP-B, which was
enriched as an NS5A interactor but did not exhibit S225 phosphorylation dependence.
Validation of S225 phosphorylation-dependent interacting proteins. We next
sought to validate the proteomic analysis/mass spectrometry results by a speciﬁc
immunoprecipitation approach. To this end, lysates from stable Huh7 cell lines harbor-
ing either the wild-type or S225A/S225D mutant SGRs, or control parental cells, were
immunoprecipitated with antibodies to NAP1L1, Bin1, VAP-A, or VAP-B. The immuno-
precipitates were probed with an anti-NS5A antiserum by Western blotting (Fig. 3a to
d). The adjacent graphs show quantiﬁcation of 3 independent assays. Consistent with
the proteomic analysis, wild-type and S225D mutant NS5A bound equally to all four
cellular proteins; in contrast, S225A NS5A bound weakly, or not at all, to NAP1L1, Bin1,
and VAP-A. In addition, binding to VAP-B was conﬁrmed to be less dependent on S225
phosphorylation, as there was only a 50% reduction in the level of S225A NS5A bound
to VAP-B. Input levels of NS5A and the four cellular proteins were conﬁrmed by Western
blotting of lysates and quantiﬁcation (Fig. 3e, graph). As seen previously, levels of
S225A NS5A were reduced by approximately 50%; however, this did not account for the
FIG 3 Validation of NS5A-interacting proteins NAP1L1, Bin1, VAP-A, and VAP-B. Huh7 cells stably harboring wild-type (WT), S225D, or
S225A SGRs were lysed and immunoprecipitated with antibodies to NAP1L1 (a), Bin1 (b), VAP-A (c), and VAP-B (d) prior to analysis by
Western blotting with mouse monoclonal antiserum to NS5A or antibodies to the indicated cellular proteins. The ratios of NS5A to the
cellular proteins were quantiﬁed from ﬂuorescent Western blots (n  3). Western blots are representative of three independent
experiments. (e) Levels of NS5A and cellular proteins in cytoplasmic lysates were conﬁrmed by Western blotting and quantiﬁed (graph).
Cont., control.
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reduction in levels of NS5A bound to NAP1L1, Bin1, or VAP-A. As the reduction in
expression of S225A correlated with the observed reduction in the amount of NS5A
coimmunoprecipitated with VAP-B, we conﬁrm that the NS5A–VAP-B interaction was
not dependent on S225 phosphorylation.
In order to further validate the interactions between NS5A and either NAP1L1 or
Bin1, we applied two imaging techniques to examine their colocalization and interac-
tion in Huh7 cells stably harboring SGRs. To complement conventional coimmunoﬂuo-
rescence, which can only determine colocalization, we used the proximity ligation assay
(PLA), which allows the detection of direct protein-protein interactions in intact cells
(37) PLA involves the use of oligonucleotides attached to secondary antibodies which
guide the formation of circular DNA strands when bound in close proximity (approxi-
mately 5 to 30 nm). These DNA circles then template localized rolling-circle ampliﬁca-
tion (RCA), allowing individual interacting pairs of proteins to be visualized and
enumerated in ﬁxed samples (37, 38). We were able to apply the PLA technique only for
NAP1L1 and Bin1, due to a lack of suitable antibody pairs for VAP-A and VAP-B; thus,
we also restricted the coimmunoﬂuorescence analysis to these two proteins.
Both NAP1L1 (Fig. 4a) and Bin1 (Fig. 4b) were distributed diffusely throughout the
cytoplasm; in the context of both wild-type and S225D NS5A SGR, there was extensive
colocalization with NS5A which was particularly noticeable close to the nucleus and not
so apparent at the periphery of the cell (quantiﬁcation shown in lower part of Fig. 4).
S225A NS5A showed a different picture: NS5A and either NAP1L1 or Bin1 seemed to
occupy mutually exclusive areas within the cytoplasm, and indeed, quantiﬁcation
showed no signiﬁcant colocalization. As shown in Fig. 5, we observed strong ﬂuores-
cence signals (red punctae) for both NS5A/NAP1L1 (Fig. 5a) and NS5A/Bin1 (Fig. 5b) in
the cytoplasm of Huh7 cells harboring either wild-type or S225D SGR. In contrast, no
PLA signal was observed for either NAP1L1 or Bin1 in cells harboring the S225A mutant
SGR. These data conﬁrm that NS5A interacts with both NAP1L1 and Bin1 in the
cytoplasm of SGR-harboring cells in an S225 phosphorylation-dependent fashion.
S225 phosphorylation-dependent NS5A-interacting proteins are required for
efﬁcient viral genome replication. We previously demonstrated that the S225A
mutation in the context of either an SGR or infectious virus resulted in a 1-log reduction
in genome replication (19, 24). Because this mutation also disrupted binding of NS5A
to NAP1L1, Bin1, VAP-A, and, to a lesser extent, VAP-B, we hypothesized that these
cellular proteins might play a role in genome replication. To test this, we adopted an
siRNA approach to ablate expression of each of these cellular proteins in Huh7 cells
stably harboring a wild-type JFH-1 SGR. Cells were transfected with siRNA pools
targeting different sites of NAP1L1, Bin1, VAP-A, or VAP-B or with a control nontarget-
ing siRNA and harvested at 72 hours posttransfection (hpt), and protein expression
levels were determined by Western blot analysis. As shown in Fig. 6a, ablation of
NAP1L1 and Bin1 expression was efﬁcient and resulted in a concomitant reduction in
NS5A protein levels (Fig. 6b). The siRNAs for VAP-A and VAP-B were less efﬁcient;
however, VAP-A ablation did reduce NS5A expression, although not as effectively as
NAP1L1 or Bin1. In contrast, we observed no signiﬁcant effect of the VAP-B ablation on
NS5A levels, possibly because, as reported previously, the role of VAP-B in HCV genome
replication is mediated via interactions with both NS5B and NS5A (39). As NS5A
expression levels are an indirect measure of genome replication, we also directly
assessed the levels of SGR RNA in siRNA-transfected cells by real-time quantitative PCR
(qRT-PCR) (Fig. 6c). Consistent with the effects of NAP1L1, Bin1, and VAP-A ablation, we
observed reductions of between 100- and 1,000-fold in HCV-speciﬁc RNA levels com-
pared to the levels in cells transfected with the control siRNA. Interestingly, despite the
fact that VAP-B ablation had no effect on NS5A levels (Fig. 6b), it also signiﬁcantly
reduced HCV RNA levels, although not as effectively as the other 3 targets. Lastly, we
conﬁrmed that the ablation of NAP1L1, Bin1, VAP-A, or VAP-B expression had no effect
on levels of S225A NS5A (Fig. 6d). These data conﬁrm that the S225 phosphorylation-
dependent interacting proteins NAP1L1, Bin1, and VAP-A (and, to a lesser extent,
VAP-B) are involved in HCV genome replication.
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The subcellular distribution of NS5A is regulated by S225 phosphorylation-
dependent binding to NAP1L1, Bin1, and VAP-A. As we had shown previously (Fig.
1 and reference 24), the S225A mutant NS5A exhibited a perinuclear restricted distri-
bution. We therefore considered that the loss of interaction with cellular factors might
be, at least in part, responsible for this restricted distribution. To test this hypothesis, we
again used siRNA to ablate expression of NAP1L1, Bin1, VAP-A, or VAP-B in Huh7 cells
stably harboring a wild-type SGR. Cells transfected with siRNA were analyzed by
immunoﬂuorescence with antibodies to both NS5A and the four cellular proteins. As
shown in Fig. 7a, NAP1L1 ablation led to an overall reduction in NS5A expression which
was restricted to a perinuclear distribution compared with the negative-control siRNA-
FIG 4 Colocalization of NS5A S225 mutants with cellular proteins. Parental Huh7 cells or cells stably harboring wild-type (WT), S225D, or
S225A SGRs were seeded onto coverslips and incubated for 72 h prior to ﬁxation. Cells were permeabilized and immunostained for NS5A
(red) and either NAP1L1 (a, green), or Bin1 (b, green). Scale bar, 20 m. Box-and-whisker plots show the percent colocalization between
NS5A and either NAP1L1 or Bin1. Manders’ overlap coefﬁcients M1 and M2 were used to evaluate the degree of colocalization between
two ﬂuorescent labels (red and green) in 10 cells. ****, P  0.0001.
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transfected (scrambled) or untransfected (mock) cells. To provide quantitative conﬁr-
mation of these observations, we determined NS5A spatial distribution data for 12
randomly selected cells (Fig. 7a, graph). A similar pattern was observed when Bin1 (Fig.
7b) or VAP-A (Fig. 8a) expression was ablated. In contrast, ablation of VAP-B expression
had only a modest effect on the distribution of NS5A which did not reach signiﬁcance
upon quantitative analysis (Fig. 8b). Lastly, we sought to conﬁrm that the effects of
NAP1L1, Bin1, or VAP-A ablation on NS5A distribution were not due to a reduction in
levels of expression, as an indirect consequence of the inhibition of genome replication.
To test this, Huh7-Lunet T7 cells were transfected with pTM-NS3-5B followed by
NAP1L1, Bin1, or VAP-A siRNAs. As shown in Fig. 9, the restricted distribution of NS5A
was also observed using this expression system, conﬁrming that the phenotype was not
dependent on genome replication or the level of NS5A expression. These data dem-
onstrate that S225 phosphorylation is required for the interaction of NS5A with a
number of cellular proteins and that these interactions control both the distribution of
NS5A and HCV genome replication.
DISCUSSION
In this study, we used a proteomic approach to identify cellular proteins that
interacted with NS5A in an S225 phosphorylation-dependent fashion, using afﬁnity
puriﬁcation followed by liquid chromatography-tandem mass spectrometry (LC-MS/
MS). We focused our attention on proteins that were enriched in samples derived from
OST-tagged wild-type NS5A and that were signiﬁcantly less abundant in samples from
OST-tagged NS5A (S225A).
The most intriguing S225 phosphorylation-dependent interacting proteins were
NAP1L1 and NAP1L4. These are members of the nucleosome assembly protein 1 (NAP1)
family and, as their name suggests, are nuclear proteins primarily involved in chromatin
assembly. However, they are also located in the cytoplasm, particularly during G2, and
mediate nucleocytoplasmic shuttling of histones during cell cycle progression (40). Of
the ﬁve mammalian NAP1 family members (NAP1L1 to NAP1L5), only NAP1L1 and
NAP1L4 are ubiquitously expressed, while the other three are expressed mainly in
neurons (41). NAPs have been shown to interact with proteins of a number of DNA
FIG 5 Proximity ligation assay for NS5A interactions with NAP1L1 and Bin1. Huh7 cells stably harboring wild-type, S225D, or S225A SGRs
were seeded onto coverslips and incubated for 72 h prior to ﬁxation and immunostaining for NS5A and either NAP1L1 or Bin1, followed
by PLA probe MINUS and PLUS (Sigma-Aldrich) ligation and rolling-circle ampliﬁcation (RCA). The hybridization probes were labeled with
Alexa Fluor 555 (red), and the nuclei were counterstained with DAPI (blue). Scale bars, 20 m and 2 m. For each experiment, the PLA
signals (per cell) of each sample were counted using Imaris software version 7.4 (Bitplane AG) from a minimum of 20 cells.
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FIG 6 Effects of siRNA ablation of NS5A-interacting protein expression on NS5A expression and RNA
replication. (a) Huh7 cells stably harboring a wild-type SGR were transfected with pooled siRNA targeting
NAP1L1, Bin1, VAP-A, or VAP-B or a control scrambled siRNA (Santa Cruz) at a ﬁnal concentration of 10
nM. Transfected cells were incubated in medium lacking G418, lysed at 72 hpt, and analyzed by Western
blotting. (b) Total NS5A levels were quantiﬁed from ﬂuorescent Western blots (n  3). The Western blots
are representative of three independent experiments. ****, P  0.0001 compared to the value for the
control. (c) At 72 hpt, the cells were harvested in TRIzol, total RNA was extracted, and qRT-PCR was
conducted on 100 ng of total cellular RNA using 5=-UTR TaqMan primers (53). The data are from three
independent experiments. (d) Huh7 cells stably harboring the S225A mutant SGR were transfected with
indicated siRNA and analyzed by Western blotting at 72 hpt as described for panel a.
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viruses, including papillomavirus E2 (42), Epstein-Barr virus EBNA1 (43), and KSHV LANA
(35). NAP1L1 also binds to HIV-1 Tat and Rev, and these interactions regulate viral
infectivity and the subcellular localization of the virus proteins (36, 44). Interestingly,
both NAP1L1 and NAP1L4 were previously shown to interact with both the HCV core
protein (33) and NS5A (34) when the viral proteins were expressed individually in
HEK293 cells, although in neither study were these interactions validated. In contrast,
our data reveal that in the context of the NS3-NS5B replication complex within Huh7
cells, both NAP1L1 and NAP1L4 interact with NS5A. Focusing on NAP1L1 (due to a lack
of available immunological reagents for NAP1L4), we further showed that these inter-
actions contribute to virus genome replication and the distribution of replication
complexes throughout the cytoplasm. It will be intriguing to understand the precise
role of these proteins in HCV genome replication; in this regard, NAP1 has been shown
to oligomerize (45) and NAPs function to transport histones, two attributes that may be
important for their function during the HCV life cycle.
FIG 7 Effects of siRNA ablation of NAP1L1 or Bin1 on the distribution of NS5A. Huh7 cells stably harboring a wild-type SGR were left untransfected
or were transfected with pooled siRNA targeting NAP1L1 or Bin1 or a control scrambled siRNA (Santa Cruz) at a ﬁnal concentration of 10 nM. At
72 hpt, cells were permeabilized, immunostained for NS5A (green), NAP1L1 (a, red), or Bin1 (b, red), and imaged by confocal microscopy. Scale
bars, 20 m and 5 m. Spatial data for NS5A were determined from 12 cells for each assay using the ImageJ software package. The data are
representative of three independent experiments. ****, P  0.0001 compared to the control value.
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We also identiﬁed Bin1 as an S225 phosphorylation-dependent NS5A interactor.
Bin1 contains an N-terminal BAR domain, a C-terminal SH3 domain, and a central
clathrin and adaptor binding domain (14, 26). Like other BAR domain-containing
proteins, Bin1 is involved in membrane curvature and trafﬁcking. It had previously been
shown to interact via its SH3 domain with a polyproline motif (PxxPxR) located in NS5A
LCSII (26, 27), and it also interacts with similar motifs in other viral proteins, such as
alphavirus nsP3 (46). As LCSII is distal to LCSI, this suggests that S225 phosphorylation
might effect a conformational change in NS5A that occludes the SH3 domain binding
polyproline motif; alternatively, multiple contacts between the two proteins may be
required to establish a stable interaction. The physiological role of Bin1 in regulating
membrane curvature is consistent with its recruitment by NS5A to sites of replication
where it may be involved in the rearrangements necessary to form the MW. As it is also
involved in membrane trafﬁcking, this provides a potential explanation for the perinu-
clear restriction of NS5A S225A replication complexes.
FIG 8 Effects of siRNA ablation of VAP-A or VAP-B on the distribution of NS5A. Huh7 cells stably harboring a wild-type SGR were left untransfected
or were transfected with pooled siRNA targeting VAP-A or VAP-B or a control scrambled siRNA (Santa Cruz) at a ﬁnal concentration of 10 nM. At
72 hpt, cells were permeabilized, immunostained for NS5A (green), VAP-A (a, red), or VAP-B (b, red) and imaged by confocal microscopy. Scale
bars, 20 m and 5 m. Spatial data for NS5A were determined from 12 cells for each assay using the ImageJ software package. The data are
representative of those from three independent experiments. ***, P  0.001 compared to the control value.
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Both VAP-A and VAP-B have previously been shown to bind both NS5A and NS5B
(30, 39). Interestingly, in the context of the genotype 1b Con1 isolate, residues T2185
and K2187 (corresponding to NS5A residues 215 and 217) were shown to be required
for the interaction (32). Mutations of these residues abolished the interaction with
VAP-A, although this was demonstrated using the yeast two-hybrid system. An addi-
tional culture-adaptive mutation (S2201I, corresponding to S229), could rescue the
interaction, although this mutation resulted in a loss of hyperphosphorylation. To-
gether with our data, these results suggest that LCSI and proximal sequences at the C
terminus of domain I are required for the interaction with VAP-A. Furthermore, it was
recently reported that the NS5A interaction with VAP-A was indirect and required a
bridging protein, G protein pathway suppressor 2 (GPS2) (29). VAP-A and VAP-B are
integral membrane proteins that have a range of reported functions pertaining to
FIG 9 Effects of siRNA ablation of NAP1L1, Bin1, or VAP-A on the distribution of NS5A in the absence of genome replication.
Huh7-Lunet T7 cells were left untransfected or were transfected with pooled siRNA targeting NAP1L1, Bin1, or VAP-A or a
control scrambled siRNA (Santa Cruz) at a ﬁnal concentration of 10 nM. At 48 hpt, cells were transfected with pTM-NS3-5B
plasmid. After a further 24 h, cells were permeabilized, immunostained for NS5A (green), NAP1L1 (a, red), Bin1 (b, red), or VAP-A
(c, red), and imaged by confocal microscopy. Scale bars, 20 m and 5 m. Spatial data for NS5A were determined from 20 cells
for each assay using the ImageJ software package. ****, P  0.0001 compared to the control value.
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vesicle trafﬁcking and lipid transport (30, 47). VAP-A also interacts with the oxysterol
binding protein (OSBP), which is recruited to the MW along with PI4K (48), and is
reported to regulate cholesterol transport to the MW. Although OSBP was not identiﬁed
in our proteomic study, these observations are consistent with a role for S225 phos-
phorylation in regulating MW formation and distribution via an interaction with VAP-A.
In conclusion, we propose that phosphorylation of NS5A at S225 within LCSI
contributes to efﬁcient genome replication by regulating interactions with key cellular
factors, some of which we have identiﬁed and characterized in this study. It is important
to note that multiple phosphorylation sites have been identiﬁed within LCSI, and it is
conceivable therefore that the total pool of NS5A within a cell might contain many
distinct phosphorylated species, each of which could also have a different function(s).
Identifying these distinct NS5A species is a technical challenge which is limited by the
sensitivity of mass spectrometric methods. In this context, we were previously able to
unambiguously identify by mass spectrometry an NS5A species that was phosphory-
lated within LCSI only on S222 and S225 (18). The abundance of this species is
consistent with a speciﬁc role during virus genome replication. Given the likely inter-
dependence of different phosphorylation events, exempliﬁed by recent evidence for
hierarchical phosphorylation, i.e., the requirement for S235 to be phosphorylated prior
to S238 phosphorylation (16), it will also be challenging to understand the functions of
these different NS5A species. A complete understanding of either the complexity of
NS5A phosphorylation or the functional consequences remains a distant and aspira-
tional objective. By demonstrating the role of phosphorylation in regulating NS5A-host
protein interactions, we believe that this study makes a signiﬁcant contribution to this
objective; however, it provides only a few pieces of the jigsaw puzzle! There is much yet
to be discovered.
MATERIALS AND METHODS
HCV replicon constructs. A DNA construct of the neomycin phosphotransferase (Neo) containing
subgenomic replicon pSGR-Neo-JFH-1-5A-OST, in which the One-Strep tag (OST) was introduced into the
C terminus of NS5A domain III (25), was used in this study (Fig. 1a and b). Previously, the OST has been
shown to have no effect on virus genome replication (25). Wild-type pSGR-Neo(RsrIIdel)-JFH-1-5A-OST
was ﬁrst constructed by abolishing an RsrII site within the Neo gene using a Q5 site-directed
mutagenesis kit (New England BioLabs [NEB]). Then the desired NS5A mutants from SGR-luc-JFH-1
(24) were cloned into pSGR-Neo(RsrIIdel)-JFH-1-5A-OST via ﬂanking Nsil/RsrII, and correct insertion
was conﬁrmed by sequencing.
Cell culture. Huh7 cells were maintained in Dulbecco’s modiﬁed Eagle’s medium (DMEM; Sigma-
Aldrich) supplemented with 10% fetal bovine serum (FBS), 100 IU of penicillin/ml, 100 g of strepto-
mycin/ml, and 1% nonessential amino acids (NEAA) in a humidiﬁed incubator at 37°C with 5% CO2. Huh7
cells carrying a subgenomic JFH-1 replicon (SGR-Neo-JFH-1) were maintained in the same medium
supplemented with 300 g/ml of G418 (BioPioneer). Huh7-Lunet T7 cells (expressing T7 RNA polymerase,
a kind gift from Volker Lohmann) were maintained in the same medium supplemented with 5 g/ml of
Zeocin (Life Technologies).
Electroporation of replicon RNA and generation of stable cell lines. The preparation of in vitro
transcripts and electroporations for pSGR-Neo-JFH-1-5A-OST-derived constructs were conducted as
described previously (25). In brief, 2  106 Huh7 cells in diethyl pyrocarbonate (DEPC)–phosphate-
buffered saline (PBS) were electroporated with 3 g of in vitro RNA transcripts using a square-wave
protocol at 260 V for 25 ms. Subsequently, cells were resuspended in complete DMEM and seeded at a
culture area of 1  104 cells/cm2 into 10-cm dishes. Forty-eight hours postelectroporation, the cells were
selected with 300 g/ml of G418. After 2 weeks, emerging colonies were pooled and kept under
continuous G418 selection for 1 to 2 weeks in order to establish stable SGR-harboring cell lines. The
maintenance of the S225 mutations was veriﬁed by RT-PCR and sequencing.
Afﬁnity puriﬁcation coupled to quantitative LC-MS/MS proteomics. To detect proteins bound to
OST-tagged NS5A by afﬁnity puriﬁcation and mass spectrometry, cell pellets from Huh7 cells stably
harboring NS5A wild-type (WT) and S225A and S225D mutant SGRs were prepared by snap-freezing cells
in liquid nitrogen. Cell pellets were lysed in TAP lysis buffer (50 mM Tris-HCl [pH 7.5], 100 mM NaCl, 5%
[vol/vol] glycerol, 0.2% [vol/vol] Nonidet P-40, 1.5 mM MgCl2) in the presence of protease inhibitor
cocktail (EDTA free, cOmplete; Roche), phosphatase inhibitor (PhosSTOP; Roche), and 750 U of Benzonase
(Core Facility, Max Planck Institute of Biochemistry [MPI-B]) for 30 min on ice. After incubation on ice, cell
lysates were sonicated using a Bioruptor with 15 alternating 30-s on/off cycles and clariﬁed by centrif-
ugation at 16,000  g. Subsequently, Strep-Tactin Sepharose beads (Iba) were incubated with 2 mg of
protein of clariﬁed lysate for 60 min at 4°C and washed once with TAP lysis buffer and three times with
TAP wash buffer (50 mM Tris-HCl [pH 7.5], 100 mM NaCl, 5% [vol/vol] glycerol, 1.5 mM MgCl2) lacking
Nonidet P-40 to remove residual detergent. Sample preparation and LC-MS/MS analysis were performed
as described previously (49). Brieﬂy, four independent afﬁnity puriﬁcations were performed for each bait,
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samples were sequentially digested with LysC (Wako Chemicals, USA) and trypsin (Promega), acidiﬁed
with 0.1% triﬂuoroacetic acid (TFA), desalted with C18 stage tips, and analyzed by liquid chromatography
coupled to mass spectrometry on an Orbitrap XL instrument (Thermo Fisher Scientiﬁc). Mass spectrom-
etry raw ﬁles were processed with MaxQuant software version 1.5.5.1 (50) using the built-in Andromeda
engine to search against human and JFH-1 proteomes containing forward and reverse sequences.
Additionally, the label-free quantiﬁcation (LFQ) (51) algorithm and Match Between Runs option were
used. Perseus software version 1.5.5.1 was used to further process the data. In this manner, only proteins
identiﬁed on the basis of at least two peptides and a minimum of three quantiﬁcation events in at least
one experimental group were considered. LFQ protein intensity values were log transformed and missing
values ﬁlled by imputation. Signiﬁcantly enriched proteins were determined by Welch’s t test with
permutation-based false-discovery rate (FDR) statistics, performing 250 permutations. The FDR threshold
was set to 0.01 and S0 parameter was set to 0.1 to separate background from speciﬁcally enriched
proteins. Results were plotted using R (https://www.R-project.org) and visually adapted using Adobe
Illustrator.
SDS-PAGE and Western blotting. Cells were washed twice in PBS, lysed in 1 Glasgow lysis buffer
(GLB; 1% [vol/vol] Triton X-100, 120 mM KCl, 30 mM NaCl, 5 mM MgCl2, 10% [vol/vol] glycerol, and 10
mM PIPES-NaOH, [pH 7.2], with protease and phosphatase inhibitors) and harvested by centrifugation
(2,800  g, 10 min, and 4°C) before determination and normalization of protein concentration by
bicinchoninic acid (BCA) assay (Pierce). Following separation by SDS-PAGE, proteins were transferred to
a polyvinylidene diﬂuoride (PVDF) membrane and blocked in 50% (vol/vol) Odyssey blocking (OB) buffer
(LI-COR) in Tris-buffered saline (TBS). The membrane was incubated with primary antibodies overnight at
4°C, followed by secondary antibodies for 2 h at room temperature, both prepared in 25% OB buffer.
Primary antibodies used were anti-NS5A (sheep, prepared in-house) at 1:4,000 (52), anti-NAP1L1
(rabbit; Santa Cruz) at 1:350, anti-Bin1 (rabbit; Generon) at 1:300, anti-VAP-A (rabbit; Generon) at
1:1,000, anti-VAP-B (rabbit; Generon) at 1:1,000, and anti--actin (mouse; Sigma) at 1:10,000.
Secondary antibodies were anti-rabbit, anti-sheep (800 nm), or anti-mouse (700 nm) antibodies,
used at 1:10,000 prior to imaging using a LI-COR Odyssey Sa infrared imaging system. Quantiﬁcation
of Western blots was carried out using Image Studio v3.1 (LI-COR) using a background subtraction
method.
PLA. Cells were washed with PBS before ﬁxation for 15 min at room temperature in 4% (wt/vol)
paraformaldehyde (PFA); cells were subsequently permeabilized in 0.1% (vol/vol) Triton X-100–PBS and
blocked with PBS-Tween (PBS-T) and 5% (wt/vol) bovine serum albumin (BSA) before immunostaining for
anti-NS5A (mouse monoclonal, 1:1,000) and either anti-NAP1L1 (rabbit monoclonal, 1:100) or anti-Bin1
(rabbit monoclonal, 1:50) overnight at 4°C. Coverslips were washed 3 times for 5 min in PBS-T buffer
under gentle shaking and incubated with proximity ligation assay (PLA) probes Duolink In Situ PLA Probe
Anti-Mouse PLUS (DUO92001; Sigma-Aldrich) and Duolink In Situ PLA Probe Anti-Rabbit MINUS
(DUO92005) for 2 h at 37°C. For PLA, all incubations were performed in a preheated humidity chamber
and according the manufacturer’s recommendations using a Duolink In Situ Detection Reagents Red kit
(DUO92008). Coverslips were washed 3 times for 5 min in PBS-T buffer under gentle shaking and
incubated with a DNA ligase previously diluted in ligation buffer for 30 min at 37°C. Coverslips were
washed 3 times for 5 min in PBS-T buffer under gentle shaking and incubated with a DNA polymerase
previously diluted in ampliﬁcation buffer for 90 min at 37°C. Finally, coverslips were washed for 20 min
under gentle shaking and then washed for 2 min with PBS and air dried. Coverslips were mounted with
Duolink In Situ mounting medium with 4=,6-diamidino-2-phenylindole (DAPI), and ﬂuorescence was
visualized with a Zeiss LSM880 upright microscope.
siRNA ablation. SGR-harboring Huh7 cells or Huh7-Lunet T7 cells were transfected with 10 nM
pooled siRNA (Santa Cruz) or 10 nM AllStars negative-control siRNA (Qiagen) using Lipofectamine 2000
(Invitrogen) according to the manufacturer’s protocol. sc-75871 targets NAP1L1, sc-29804 targets Bin1,
sc-61768 targets VAP-A, and sc-61770 targets VAP-B. For Huh7-Lunet T7 cell experiments, the cells were
transfected with pTM-NS3-5B plasmid at 48 h posttransfection (hpt). Cells were incubated in DMEM
supplemented with 5% fetal calf serum (FCS) and harvested at 72 hpt. Proteins and total RNA were
isolated with TRIzol (Life Technologies), and subsequent Western blotting and real-time quantitative PCR
(qRT-PCR) were performed.
RNA extraction and qRT-PCR. To quantify the number of HCV genomes, total cell RNA was
extracted using TRIzol reagent by following the manufacturer’s instructions (Invitrogen). Total extracted
cellular RNA (100 ng) was analyzed using a one-step qRT-PCR TaqMan-based kit (Eurogentec), with
primers and probe designed against the 5= untranslated region (UTR) as described previously (19, 53).
Immunoﬂuorescence and confocal microscopy. Cells were washed with PBS before ﬁxation for 20
min in 4% (wt/vol) PFA; cells were subsequently permeabilized in 0.1% (vol/vol) Triton X-100 and PBS and
blocked with PBS-T and 5% (wt/vol) BSA before being immunostained with primary antibody as
described above. Various ﬂuorescently conjugated secondary antibodies were used at 1:500 (Life
Technology). Nuclei were counterstained with DAPI. Confocal microscopy images were acquired on a
Zeiss LSM880 upright microscope with Airyscan; postacquisition analysis was conducted using Zen
software (Zen version 2015 black edition 2.3; Zeiss) or Fiji (version 1.49) software (54).
dSTORM. The direct stochastic optical reconstruction microscopy (dSTORM) system described pre-
viously (55) was modiﬁed with a cylindrical lens (f  150 mm, where f is focal length; Thorlabs). Round
glass 25-mm-diameter coverslips (Warner Instruments) were cleaned in a 1:1:5 solution of NH3 (aq), H2O2,
and H2O at 80°C for 16 h. Cells stably harboring NS5A wild-type, S225D, and S225A mutant subgenomic
replicons were seeded onto cleaned coverslips at 1 105 cells per well in six-well plates. Coverslips were
ﬁxed in 2% (wt/vol) PFA in normal medium for 10 min, permeabilized in 0.2% Triton X-100 in PBS for 10
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min, and blocked in 1% (vol/vol) normal donkey serum (Sigma-Aldrich) for 1 h. Mouse monoclonal
anti-NS5A antibody was directly labeled at an approximately 1:1 ratio using the carboxylic acid succin-
imidyl ester of the photoswitchable dye Alexa Fluor 647 (Life Technologies) in PBS containing 125 mM
NaHCO3 in the dark for 30 min. Unincorporated dye was removed by size exclusion using Zeba microspin
desalting columns (Thermo Fisher Scientiﬁc). Immunostaining was conducted with directly labeled
antibody (1:2,000) for 1 h. Coverslips were then treated with 0.01% poly-L-lysine (Sigma-Aldrich) for 10
min and incubated with a suspension of 150-nm gold nanoparticles (Sigma-Aldrich).
The image acquisition and processing software was used as described previously (56). Labels were
stochastically activated with 642-nm laser excitation under wide-ﬁeld illumination in the presence of
ﬂuorescence quenching buffer (glucose oxidase [10 U], catalase [50 U], 12.5 mg ml1 of D-glucose, 1 mM
2-mercaptoethylamine in PBS [pH 8.0]). Data sets consisted of 11,000 image frames at a frame rate of 20
Hz. Localized emission events were binned into histograms for display and correction of image distortion
by the cylindrical lens. Image smoothing was conducted in R using kernel density estimation to reﬂect
x-y-z localization precisions measured from ﬁducial markers, and z-stacks were visualized in Fiji. Cluster-
ing analysis was conducted in Python using density-based spatial clustering of applications with noise
(DBSCAN) (57) on the localization coordinates extracted from the palm3d software (MinPts 30;  150
nm). Cluster sizes were determined from the mean Euclidean distance between all localizations in
identiﬁed clusters. Image analysis in R and Python used custom scripts (available on request), and
statistical tests were conducted in GraphPad Prism using a one-way analysis of variance (ANOVA) with
Tukey’s multiple comparisons.
Quantiﬁcation of NS5A distribution. For quantiﬁcation of NS5A spatial arrangement, images were
acquired with the same acquisition parameters, but with variable gain to ensure correct exposure. The
spatial coordinates of NS5A were determined using the FindFoci function of the GDSC plugin for Fiji, with
the nuclear envelope being manually outlined (utilizing the DAPI staining as a reference) and coordinates
generated by Fiji. The distance from each NS5A to the nuclear envelope was then determined using
trigonometry. NS5A spatial distribution data were generated for 12 randomly selected cells for each
replicon variant and data combined into a box-and-whisker plot.
For colocalization analysis, Manders’ overlap coefﬁcient was calculated using ImageJ software with
Just Another Co-localization Plugin (JACoP) (National Institutes of Health). Coefﬁcient M1 reﬂects the
fraction of the anti-NS5A signal that overlaps either the anti-NAP1L1 or anti-Bin1 signal. Coefﬁcient M2
reﬂects the fraction of either the anti-NAP1L1 or anti-Bin1 signal that overlaps the anti-NS5A signal.
Coefﬁcient values range from 0 to 1, corresponding to nonoverlapping images and 100% colocalization
images, respectively. Colocalization calculations were performed on 10 cells from at least two inde-
pendent experiments.
Statistics. Data sets were analyzed using Student’s t test assuming a two-tailed, unequal variance to
determine statistical difference from the wild type (WT) (n  3 or greater throughout).
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